TNFAIP3 and myeloid sarcoma: Previously, we reported a decrease in gene expression level of TNFAIP3 in whole blood and in peripheral blood mononuclear cells (PBMCs) obtained from treatment naïve MS patients in comparison to healthy controls (HC) [12,13,14,15].